Does DONANEMAB-AZBT Cause Amyloid related imaging abnormalities? 80 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Amyloid related imaging abnormalities have been filed in association with DONANEMAB-AZBT. This represents 7.9% of all adverse event reports for DONANEMAB-AZBT.
80
Reports of Amyloid related imaging abnormalities with DONANEMAB-AZBT
7.9%
of all DONANEMAB-AZBT reports
4
Deaths
13
Hospitalizations
How Dangerous Is Amyloid related imaging abnormalities From DONANEMAB-AZBT?
Of the 80 reports, 4 (5.0%) resulted in death, 13 (16.3%) required hospitalization, and 2 (2.5%) were considered life-threatening.
Is Amyloid related imaging abnormalities Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DONANEMAB-AZBT. However, 80 reports have been filed with the FAERS database.
What Other Side Effects Does DONANEMAB-AZBT Cause?
Amyloid related imaging abnormality-oedema/effusion (185)
Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits (139)
Headache (111)
Infusion related reaction (97)
Flushing (68)
Cerebral haemorrhage (54)
Dizziness (48)
Nausea (44)
Cerebral microhaemorrhage (41)
Confusional state (40)
What Other Drugs Cause Amyloid related imaging abnormalities?
Which DONANEMAB-AZBT Alternatives Have Lower Amyloid related imaging abnormalities Risk?
DONANEMAB-AZBT vs DONEPEZIL
DONANEMAB-AZBT vs DONEPEZIL\DONEPEZIL
DONANEMAB-AZBT vs DONEPEZIL\MEMANTINE
DONANEMAB-AZBT vs DONEPEZIL\OMEPRAZOLE\OMEPRAZOLE
DONANEMAB-AZBT vs DONOR HUMAN STOOL